Novel brain-targeting 3-n-butylphthalide prodrugs for ischemic stroke treatment.

Published on Jun 1, 2021in Journal of Controlled Release7.727
· DOI :10.1016/J.JCONREL.2021.05.045
Honglin Xiang (Sichuan University), Qiang Zhang (Sichuan University)+ 5 AuthorsLing Zhang9
Estimated H-index: 9
(Sichuan University)
Sources
Abstract
Currently, ischemic stroke is the leading cause of disability and death worldwide, and the performance of corresponding drugs is often unsatisfactory owing to the complex pathological processes and the impediment of the blood-brain barrier (BBB). Here, we employed various tertiary amino groups, including different linear, cyclic, and bimolecular drug structures, to modify 3-n-butylphthalide (NBP), a natural product used for ischemic stroke treatment, which has poor bioavailability, to generate a series of six prodrugs. These prodrugs showed significantly improved solubility and cellular uptake, which were primarily driven by putative pyrilamine cationic transporters. They also displayed more efficient brain delivery in vivo, reaching as high as 21.5-fold brain accumulation increase compared with NBP, leading to much higher bioavailability and stronger therapeutic effects. The toxicity of these molecules is also lower or similar to that of unmodified NBP. We showed that the tertiary amino group-modified NBP prodrugs are effective and safe for treating ischemic stroke with significantly enhanced druggability; hence, they have potential for further clinical development.
📖 Papers frequently viewed together
2014
8 Authors (Yinyi Sun, ..., Xiaojiang Sun)
3 Citations
21 Citations
References51
Newest
#1Jean-Michel Rabanel (Institut national de la recherche scientifique)H-Index: 14
#2Pierre-Alexandre Piec (Institut national de la recherche scientifique)H-Index: 1
Last. Charles Ramassamy (Institut national de la recherche scientifique)H-Index: 32
view all 5 authors...
Treatments of neurodegenerative diseases (NDDs) are severely hampered by the presence of the blood-brain barrier (BBB) precluding efficient brain drug delivery. The development of drug nanocarriers aims at increasing the brain therapeutic index would represent a real progress in brain disease management. PEGylated polyester nanoparticles (NPs) are intensively tested in clinical trials for improved drug delivery. Our working hypothesis was that some surface parameters and size of NPs could favor ...
7 CitationsSource
#1Hansen Chen (HKU: University of Hong Kong)H-Index: 14
#2Yacong He (HKU: University of Hong Kong)H-Index: 1
Last. Jiangang Shen (HKU: University of Hong Kong)H-Index: 50
view all 5 authors...
Abstract Oxidative/nitrosative stress and neuroinflammation are critical pathological processes in cerebral ischemia-reperfusion injury, and their intimate interactions mediate neuronal damage, blood-brain barrier (BBB) damage and hemorrhagic transformation (HT) during ischemic stroke. We review current progress towards understanding the interactions of oxidative/nitrosative stress and inflammatory responses in ischemic brain injury. The interactions between reactive oxygen species (ROS)/reactiv...
12 CitationsSource
#1Anuska V. Andjelkovic (UM: University of Michigan)H-Index: 35
#2Svetlana M. Stamatovic (UM: University of Michigan)H-Index: 23
Last. Richard F. Keep (UM: University of Michigan)H-Index: 92
view all 5 authors...
The complexity of the blood-brain barrier (BBB) and neurovascular unit (NVU) was and still is a challenge to bridge. A highly selective, restrictive and dynamic barrier, formed at the interface of blood and brain, the BBB is a "gatekeeper" and guardian of brain homeostasis and it also acts as a "sensor" of pathological events in blood and brain. The majority of brain and cerebrovascular pathologies are associated with BBB dysfunction, where changes at the BBB can lead to or support disease devel...
11 CitationsSource
#1José Marco-Contelles (CSIC: Spanish National Research Council)H-Index: 39
#2Yihua Zhang (CPU: China Pharmaceutical University)H-Index: 34
3-n-Butylphthalide (NBP) as well as its derivatives and analogues (NBPs), in racemic or enantiomerically pure forms, possess potent and diverse pharmacological properties, and have shown a great po...
2 CitationsSource
#1Salim S. ViraniH-Index: 62
#2Alvaro AlonsoH-Index: 94
Last. Connie W. TsaoH-Index: 25
view all 41 authors...
Background: The American Heart Association, in conjunction with the National Institutes of Health, annually reports on the most up-to-date statistics related to heart disease, stroke, and cardiovas...
1,689 CitationsSource
#1Zhe-Qi Xu ('SMMU': Second Military Medical University)H-Index: 7
#2Yi ZhouH-Index: 1
Last. Chong Liu ('SMMU': Second Military Medical University)H-Index: 15
view all 5 authors...
DL-3-n-butylphthalide (NBP) is widely used as a neuroprotective drug for ischemic stroke in China. There is, however, no established evidence on its efficacy and safety for patients with ischemic s...
18 CitationsSource
#1Shubei Ma (Capital Medical University)H-Index: 2
#2Jianyi Wang (University of Pittsburgh)H-Index: 4
Last. Jun Chen (University of Pittsburgh)H-Index: 13
view all 12 authors...
Background and Purpose— Type 2 diabetes mellitus (T2DM) is a major comorbidity that exacerbates ischemic brain injury and worsens functional outcome after stroke. T2DM is known to aggravate white m...
35 CitationsSource
#1Longjian Huang (Peking Union Medical College)H-Index: 5
#2Shan Wang (Peking Union Medical College)H-Index: 4
Last. Ying Peng (Peking Union Medical College)H-Index: 21
view all 9 authors...
Abstract Discovering effective agents to slow or stop neurodegeneration is a challenging task. Over decades, only a few drugs were approved by Food and Drug Administration (FDA) and most ended in failure. The lessons learned have switched the strategy of drug discovery from designing highly selective ligands to a network pharmacology approach. This enables many natural products like butylphthalide (NBP) once again to be regarded as a valuable source of leads for drug discovery. In this review, w...
17 CitationsSource
#1Fan GaoH-Index: 7
#2Chen ChenH-Index: 3
Last. Jian-Feng HanH-Index: 3
view all 8 authors...
PURPOSE: The aspartate transaminase/alanine transaminase ratio (De Ritis ratio, AAR) was reported to be associated with patients' prognosis in certain diseases recently. The objective of the current study was to determine the association between the AAR at admission and poor outcome at 3 months in acute ischemic stroke (AIS) patients. PATIENTS AND METHODS: This retrospective cohort study included patients who experienced their first-ever AIS between June 2015 and March 2016. The primary outcome ...
14 CitationsSource
#1Xinyi Wang (Sichuan University)H-Index: 6
#2Bowen Qi (Sichuan University)H-Index: 6
Last. Zhirong Zhang (Sichuan University)H-Index: 63
view all 8 authors...
Abstract Blood-brain barrier (BBB) represents the greatest challenge that hampers therapeutic molecules entering the brain. Here, we described a novel brain-specific delivery strategy targeting to pyrilamine-sensitive H + /OC antiporter to facilitate therapeutic molecules cross the BBB and penetrate into the brain. In this study, four cyclic tertiary amines were selected as the brain-targeting moieties to modify naproxen (NP), a non-steroidal anti-inflammatory drug. The obtained NP conjugates di...
9 CitationsSource
Cited By0
Newest